0001104659-23-079367.txt : 20230710 0001104659-23-079367.hdr.sgml : 20230710 20230710090015 ACCESSION NUMBER: 0001104659-23-079367 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20230706 ITEM INFORMATION: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20230710 DATE AS OF CHANGE: 20230710 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Accelerate Diagnostics, Inc CENTRAL INDEX KEY: 0000727207 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 841072256 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-31822 FILM NUMBER: 231078348 BUSINESS ADDRESS: STREET 1: 3950 S. COUNTRY CLUB ROAD #470 STREET 2: BUILDING 3-307 CITY: TUCSON STATE: AZ ZIP: 85714 BUSINESS PHONE: 303-863-8088 MAIL ADDRESS: STREET 1: 3950 S. COUNTRY CLUB ROAD #470 STREET 2: BUILDING 3-307 CITY: TUCSON STATE: AZ ZIP: 85714 FORMER COMPANY: FORMER CONFORMED NAME: ACCELR8 TECHNOLOGY CORP DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: HYDRO SEEK INC DATE OF NAME CHANGE: 19880802 8-K 1 tm2320924d1_8k.htm FORM 8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported)

July 6, 2023

Accelerate Diagnostics, Inc.

(Exact name of registrant as specified in its charter)

Delaware

(State or other jurisdiction of incorporation)

001-31822		84-1072256
(Commission File Number)		(IRS Employer Identification No.)

3950 South Country Club Road, Suite 470, Tucson, Arizona		85714
(Address of principal executive offices)		(Zip Code)

(520) 365-3100

(Registrant’s telephone number, including area code)

Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

¨

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol

Name of each exchange on which
registered

Common Stock, $0.001 par value per share

AXDX

The Nasdaq Stock Market LLC

(The Nasdaq Capital Market)

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ¨

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Item 3.01.

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

As previously reported, on January 5, 2023, the Company received a deficiency letter from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market (“Nasdaq”) notifying the Company that, for the last 30 consecutive business days, the closing bid price for the Company’s common stock had been below the minimum $1.00 per share requirement for continued inclusion on The Nasdaq Capital Market (the “Capital Market”) pursuant to Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”). At that time, the Company was granted a period of 180 calendar days, or until July 5, 2023, to regain compliance with the Minimum Bid Price Requirement.

On July 6, 2023, the Company received a determination letter from the Staff notifying the Company that it had not regained compliance with the Minimum Bid Price Requirement as of July 5, 2023 in compliance with Nasdaq Listing Rule 5550(a)(2). Accordingly, the Staff has determined that unless the Company files an appeal of this determination and timely requests a hearing before a Nasdaq Hearing Panel (the “Panel”), the trading of the Company’s common stock will be suspended at the opening of business on July 17, 2023 and the Company’s securities will be delisted from the Capital Market.

The Company has requested a hearing before the Panel to appeal the Staff’s determination and present a plan to regain compliance with the Minimum Bid Price Requirement. As part of the Company’s compliance plan to regain compliance with the Minimum Bid Price Requirement, the Company will effect a reverse stock split, as described more fully below. The hearing request has stayed the suspension of the Company’s securities or delisting actions pending the Panel’s decision and the expiration of any additional extension period granted by the Panel following the hearing.

Notwithstanding, there can be no assurance that the Panel will accept the Company’s compliance plan, that the appeal will be successful, that the Company will be able to regain compliance with the Minimum Bid Price Requirement or that the Company will otherwise be in compliance with other applicable Nasdaq Listing Rules. If the Company’s appeal is denied by the Panel or if the Company fails to regain compliance with Nasdaq Listing Rules during any additional compliance period granted by the Panel, the Company’s common stock will be subject to delisting from the Capital Market.

Item 8.01.

Other Events.

On July 10, 2023, the Company issued a press release announcing that its Board of Directors (the “Board”) has approved a 1-for-10 reverse stock split (the “Reverse Stock Split”) of the Company’s common stock. A copy of the press release is filed herewith as Exhibit 99.1 and is incorporated by reference into this Item 8.01.

The Reverse Stock Split is expected to become effective on July 11, 2023 at 5:00 p.m. ET (the “Effective Time”), with shares to begin trading on a split-adjusted basis at market open on July 12, 2023. In connection with the Reverse Stock Split, every 10 shares of the Company’s common stock issued and outstanding as of the Effective Time will be automatically converted into one share of the Company’s common stock. The Company’s stockholders will be entitled to receive cash in lieu of any fractional shares they would otherwise be entitled to receive in the Reverse Stock Split.

As a result of the Reverse Stock Split, proportionate adjustments will be made to the number of shares of the Company’s common stock underlying the Company’s outstanding equity awards, warrants and convertible notes and the number of shares issuable under the Company’s equity incentive plans and other existing agreements, as well as the exercise or conversion price, as applicable.

Item 9.01.

Financial Statements and Exhibits.

(d) Exhibits.

Exhibit Number		Description
99.1		Press release, dated July 10, 2023
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	ACCELERATE DIAGNOSTICS, INC.
	(Registrant)
Date: July 10, 2023
	/s/ David Patience
	David Patience
	Chief Financial Officer

EX-99.1 2 tm2320924d1_ex99-1.htm EXHIBIT 99.1

Exhibit 99.1

Accelerate Diagnostics Announces 1-for-10 Reverse Stock Split

TUCSON, Ariz., July 10, 2023 /PRNewswire/ -- Accelerate Diagnostics, Inc., (NASDAQ:AXDX) (the “Company”) a leading provider of innovative rapid diagnostic solutions, announced that it will conduct a reverse stock split of its outstanding shares of common stock at a ratio of 1-for-10. The reverse stock split will become effective at 5:00 p.m. Eastern Time, on July 11, 2023. The Company’s common stock will begin trading on a post-split basis at the market open on July 12, 2023, under the Company’s existing trading symbol “AXDX”. The reverse stock split is part of the Company’s plan to regain compliance with the Minimum Bid Price Requirement of $1.00 per share required to maintain continued listing on The Nasdaq Capital Market, among other benefits.

The reverse stock split was approved by the Company's stockholders at the Company’s Annual Meeting of Stockholders held on May 19, 2023 to be effected in the Board’s discretion within approved parameters. The final ratio was approved by the Company's Board on July 7, 2023.

The reverse stock split reduces the number of shares of the Company’s outstanding common stock from approximately 144 million shares to approximately 14 million shares, subject to adjustment due to the payment of cash in lieu of fractional shares. As a result of the Reverse Stock Split, proportionate adjustments will be made to the number of shares of the Company’s common stock underlying the Company’s outstanding equity awards, warrants and convertible notes and the number of shares issuable under the Company’s equity incentive plans and other existing agreements, as well as the exercise or conversion price, as applicable. There will be no change to the number of authorized shares or the par value per share.

Information for AXDX Stockholders

As a result of the reverse stock split, every ten pre-split shares of common stock outstanding will become one share of common stock. The Company’s transfer agent, Broadridge Financial Solutions, Inc., will serve as the exchange agent for the reverse stock split.

Registered stockholders holding pre-split shares of the Company’s common stock electronically in book-entry form are not required to take any action to receive post-split shares. Those stockholders who hold their shares in brokerage accounts or in “street name” will have their positions automatically adjusted to reflect the reverse stock split, subject to each broker's particular processes, and will not be required to take any action in connection with the reverse stock split. Stockholders holding shares of the Company’s common stock in certificate form will receive a transmittal letter from Broadridge with instructions as soon as practicable after the effective date.

No fractional shares will be issued in connection with the reverse stock split. Stockholders who otherwise would be entitled to receive fractional shares will receive a cash payment in lieu of such fractional shares.

About Accelerate Diagnostics, Inc.

Accelerate Diagnostics, Inc. is an in vitro diagnostics company dedicated to providing solutions for the global challenges of antibiotic resistance and sepsis. The Accelerate Pheno^® system and Accelerate PhenoTest^® BC kit combine several technologies aimed at reducing the time clinicians must wait to determine the most optimal antibiotic therapy for deadly infections. The FDA cleared system and kit fully automate the sample preparation steps to report phenotypic antibiotic susceptibility results in approximately 7 hours direct from positive blood cultures. Recent external studies indicate the solution offers results 1-2 days faster than existing methods, enabling clinicians to optimize antibiotic selection and dosage specific to the individual patient days earlier.

“Accelerate Diagnostics” and diamond shaped logos and marks are registered trademarks of Accelerate Diagnostics, Inc.

For more information about the company, its products and technology, or recent publications, visit axdx.com.

Forward-Looking Statements

Certain of the statements made in this press release are “forward-looking” or may have “forward-looking” implications within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, related to our future stock price, the effect of the reverse stock split on stockholders and compliance with listing standards. Actual results or developments may differ materially from those projected or implied in these forward-looking statements. Information about the risks and uncertainties faced by Accelerate Diagnostics is contained in the section captioned "Risk Factors" in the company's most recent Annual Report on Form 10-K, filed with the Securities and Exchange Commission on March 31, 2023, and in other reports that the company files with the Securities and Exchange Commission. In addition, the company's forward-looking statements could be affected by general industry and market conditions and regulatory approvals. You are cautioned not to place undue reliance on these forward-looking statements, which are made only as of the date of this press release. Except as required by federal securities laws, the company undertakes no obligation to update or revise these forward-looking statements to reflect new events, uncertainties or other contingencies.

SOURCE Accelerate Diagnostics, Inc.

For further information: Investor Inquiries & Media Contact: Laura Pierson, Accelerate Diagnostics, +1 520 365-3100, investors@axdx.com

EX-101.SCH 3 axdx-20230706.xsd XBRL TAXONOMY EXTENSION SCHEMA 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 axdx-20230706_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 5 axdx-20230706_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 6 R1.htm IDEA: XBRL DOCUMENT

Cover	Jul. 06, 2023
Cover [Abstract]
Document Type	8-K
Amendment Flag	false
Document Period End Date	Jul. 06, 2023
Entity File Number	001-31822
Entity Registrant Name	Accelerate Diagnostics, Inc.
Entity Central Index Key	0000727207
Entity Tax Identification Number	84-1072256
Entity Incorporation, State or Country Code	DE
Entity Address, Address Line One	3950 South Country Club Road
Entity Address, Address Line Two	Suite 470
Entity Address, City or Town	Tucson
Entity Address, State or Province	AZ
Entity Address, Postal Zip Code	85714
City Area Code	520
Local Phone Number	365-3100
Written Communications	false
Soliciting Material	false
Pre-commencement Tender Offer	false
Pre-commencement Issuer Tender Offer	false
Title of 12(b) Security	Common Stock, $0.001 par value per share
Trading Symbol	AXDX
Security Exchange Name	NASDAQ
Entity Emerging Growth Company	false

XML 7 tm2320924d1_8k_htm.xml IDEA: XBRL DOCUMENT 0000727207 2023-07-06 2023-07-06 iso4217:USD shares iso4217:USD shares 0000727207 false 8-K 2023-07-06 Accelerate Diagnostics, Inc. DE 001-31822 84-1072256 3950 South Country Club Road Suite 470 Tucson AZ 85714 520 365-3100 false false false false Common Stock, $0.001 par value per share AXDX NASDAQ false EXCEL 8 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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

-8?20$3;8T.P6BP^ M0"X99K>]9!:G%C:^?VZH:TE[VE-S9NMQ=%A?BTX'HE'QY%V)N:I%FGJ:QJ,';>$<-!)U4 MQ-Z*0CZFL6&P9:P!Q+MTFF6SU%L,9KD8M;:X1+_)UW,#EC MQ ,ZE._<]'<')O$8T.,5RMQD)HDU75Z(\4I!K-L53,[E9C(,]L""Q1]ZUYG\ MM(?8,V(/'U:-Y&:6J6"%'*7?Z/6M>CR#+@^H%7I")\!K*_#,U#88CIV,IDAO M8O0]C.=0XIS_4R-5%1:PIJ+U$&3HD<%U!D.LL8DF"=9#;E9T!N[RZ .;O\P>=0>6N=6RKV'5[+E M&''\GN4/4$L#!!0 ( =(ZE8D'INBK0 /@! : >&PO7W)E;',O M=V]R:V)O;VLN>&UL+G)E;'.UD3T.@S ,A:\2Y0 U4*E#!4Q=6"LN$ 7S(Q(2 MQ:X*MR^% 9 Z=&&RGBU_[\E.GV@4=VZ@MO,D1FL&RF3+[.\ I%NTBB[.XS!/ M:A>LXEF&!KS2O6H0DBBZ0=@S9)[NF:*'3^ 5!+ P04 " '2.I699!YDAD! #/ P $P %M#;VYT M96YT7U1Y<&5S72YX;6RMDTU.PS 0A:\295LE+BQ8H*8;8 M=< %C3QJK_I-G M6M+;,T[:2J 2%85-K'C>O,^>EZS>CQ&PZ)WUV)0=47P4 E4'3F(=(GBNM"$Y M2?R:MB)*M9-;$/?+Y8-0P1-XJBA[E.O5,[1R;ZEXZ7D;3?!-FI6.5 MZ*U .EK >MKBRAE#VQH%.JB]XY8:8P*IL0,@9^O1=#%-)IXPC,^[V?S!9@K( MRDT*$3FQ!'_'G2/)W55D(TADIJ]X(;+U[/M!3EN#OI'-X_T,:3?D@6)8YL_X M>\87_QO.\1'"[K\_L;S63AI_YHOA/UY_ 5!+ 0(4 Q0 ( =(ZE8'04UB M@0 +$ 0 " 0 !D;V-0&UL4$L! M A0#% @ !TCJ5B?88=[M *P( !$ ( !KP &1O M8U!R;W!S+V-O&UL4$L! A0#% @ !TCJ5IE&PO=V]R:W-H M965T&UL4$L! A0#% @ !TCJ5I^@&_"Q @ X@P T M ( !H@P 'AL+W-T>6QE&PO M=V]R:V)O;VLN>&UL4$L! A0#% @ !TCJ5B0>FZ*M ^ $ !H M ( !QQ$ 'AL+U]R96QS+W=O9(9 0 SP, !, ( !K!( %M#;VYT D96YT7U1Y<&5S72YX;6Q02P4& D "0 ^ @ ]A, end XML 9 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 10 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 11 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.2 html 1 23 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://acceleratediagnostics.com/role/Cover Cover Cover 1 false false All Reports Book All Reports tm2320924d1_8k.htm axdx-20230706.xsd axdx-20230706_lab.xml axdx-20230706_pre.xml tm2320924d1_ex99-1.htm http://xbrl.sec.gov/dei/2023 true false JSON 13 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "tm2320924d1_8k.htm": { "axisCustom": 0, "axisStandard": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 23 }, "contextCount": 1, "dts": { "inline": { "local": [ "tm2320924d1_8k.htm" ] }, "labelLink": { "local": [ "axdx-20230706_lab.xml" ] }, "presentationLink": { "local": [ "axdx-20230706_pre.xml" ] }, "schema": { "local": [ "axdx-20230706.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] } }, "elementCount": 59, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2023": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 23, "memberCustom": 0, "memberStandard": 0, "nsprefix": "axdx", "nsuri": "http://acceleratediagnostics.com/20230706", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "p", "body", "html" ], "baseRef": "tm2320924d1_8k.htm", "contextRef": "AsOf2023-07-06", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "menuCat": "Cover", "order": "1", "role": "http://acceleratediagnostics.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "p", "body", "html" ], "baseRef": "tm2320924d1_8k.htm", "contextRef": "AsOf2023-07-06", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2023", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r11", "r13", "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r19" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r16" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r17" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "xbrltype": "trueItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r8" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r9" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r10" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r18" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "xbrltype": "booleanItemType" } }, "unitCount": 3 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r10": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r11": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r12": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r13": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r14": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r15": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r16": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r17": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r18": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r19": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r6": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r7": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r8": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r9": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d", "role": "http://www.xbrl.org/2003/role/presentationRef" } }, "version": "2.2" } ZIP 14 0001104659-23-079367-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001104659-23-079367-xbrl.zip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end